FI104255B1 - Förfarande för framsätllning av fusionsproteiner innehållande N-terminalfragmenter av mänsklig serumalbumin - Google Patents

Förfarande för framsätllning av fusionsproteiner innehållande N-terminalfragmenter av mänsklig serumalbumin

Info

Publication number
FI104255B1
FI104255B1 FI915073A FI915073A FI104255B1 FI 104255 B1 FI104255 B1 FI 104255B1 FI 915073 A FI915073 A FI 915073A FI 915073 A FI915073 A FI 915073A FI 104255 B1 FI104255 B1 FI 104255B1
Authority
FI
Finland
Prior art keywords
preparation
fusion proteins
serum albumin
human serum
proteins containing
Prior art date
Application number
FI915073A
Other languages
English (en)
Finnish (fi)
Other versions
FI104255B (sv
FI915073A0 (fi
Inventor
David James Ballance
Original Assignee
Delta Biotechnology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Delta Biotechnology Ltd filed Critical Delta Biotechnology Ltd
Publication of FI915073A0 publication Critical patent/FI915073A0/fi
Application granted granted Critical
Publication of FI104255B publication Critical patent/FI104255B/sv
Publication of FI104255B1 publication Critical patent/FI104255B1/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/31—Fusion polypeptide fusions, other than Fc, for prolonged plasma life, e.g. albumin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI915073A 1989-04-29 1991-10-28 Förfarande för framsätllning av fusionsproteiner innehållande N-terminalfragmenter av mänsklig serumalbumin FI104255B1 (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8909916 1989-04-29
GB898909916A GB8909916D0 (en) 1989-04-29 1989-04-29 Polypeptides
PCT/GB1990/000650 WO1990013653A1 (en) 1989-04-29 1990-04-26 Fusion proteins containing n-terminal fragments of human serum albumin
GB9000650 1990-04-26

Publications (3)

Publication Number Publication Date
FI915073A0 FI915073A0 (fi) 1991-10-28
FI104255B FI104255B (sv) 1999-12-15
FI104255B1 true FI104255B1 (sv) 1999-12-15

Family

ID=10656000

Family Applications (1)

Application Number Title Priority Date Filing Date
FI915073A FI104255B1 (sv) 1989-04-29 1991-10-28 Förfarande för framsätllning av fusionsproteiner innehållande N-terminalfragmenter av mänsklig serumalbumin

Country Status (12)

Country Link
EP (1) EP0470165A1 (sv)
JP (1) JP2781459B2 (sv)
KR (1) KR100227167B1 (sv)
AU (1) AU630450B2 (sv)
CA (1) CA2015687C (sv)
FI (1) FI104255B1 (sv)
GB (2) GB8909916D0 (sv)
HU (1) HUT61049A (sv)
IE (1) IE67651B1 (sv)
IL (1) IL94243A (sv)
WO (1) WO1990013653A1 (sv)
ZA (1) ZA903237B (sv)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610148A (en) * 1991-01-18 1997-03-11 University College London Macroscopically oriented cell adhesion protein for wound treatment
US5629287A (en) * 1991-01-18 1997-05-13 University College London Depot formulations
FR2686900B1 (fr) * 1992-01-31 1995-07-21 Rhone Poulenc Rorer Sa Nouveaux polypeptides ayant une activite de stimulation des colonies de granulocytes, leur preparation et compositions pharmaceutiques les contenant.
FR2686899B1 (fr) * 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
WO1994016085A2 (en) * 1992-12-30 1994-07-21 Zymogenetics, Inc. Hybrid proteins having cross-linking and tissue-binding activities
GB9408466D0 (en) * 1994-04-27 1994-06-22 Univ Nottingham Cloning and functional expression of neurotoxins
US5543308A (en) * 1994-10-18 1996-08-06 New England Biolabs, Inc. Isolated DNA encoding the FSEI restriction endonuclease and related methods for producing the same
US5877149A (en) 1995-06-07 1999-03-02 Beaulieu; Andre Deepithelialized skin diffusion cell system
US5641483A (en) * 1995-06-07 1997-06-24 Beaulieu; Andre Wound healing formulations containing human plasma fibronectin
US6423512B1 (en) 1996-07-26 2002-07-23 Novartis Ag Fusion polypeptides
PE99498A1 (es) * 1996-07-26 1999-01-21 Novartis Ag Polipeptidos de fusion
US5932693A (en) * 1996-12-10 1999-08-03 Washington University Antithrombotic peptides
EP1049790A1 (en) 1998-01-23 2000-11-08 Novo Nordisk A/S Process for making desired polypeptides in yeast
EP1088084B1 (en) 1998-06-15 2006-09-13 GTC Biotherapeutics, Inc. Erythropoietin analog-human serum albumin fusion protein
JP2003530838A (ja) * 2000-04-12 2003-10-21 ヒューマン ゲノム サイエンシズ インコーポレイテッド アルブミン融合タンパク質
DE60232083D1 (de) 2001-08-15 2009-06-04 Takara Bio Inc Expansionskulturverfahren für antigenspezifische zytotoxische t-lymphozyten
CA2471363C (en) 2001-12-21 2014-02-11 Human Genome Sciences, Inc. Albumin fusion proteins
WO2003080817A1 (en) 2002-03-25 2003-10-02 Takara Bio Inc. Process for producing cytotoxic lymphocyte
KR20060039940A (ko) * 2003-08-22 2006-05-09 다카라 바이오 가부시키가이샤 세포 상해성 림프구의 제조 방법
US7850970B2 (en) 2003-08-26 2010-12-14 The Regents Of The University Of Colorado Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections
GB0329722D0 (en) 2003-12-23 2004-01-28 Delta Biotechnology Ltd Modified plasmid and use thereof
GB0329681D0 (en) 2003-12-23 2004-01-28 Delta Biotechnology Ltd Gene expression technique
DK2330200T3 (en) 2004-12-23 2017-07-24 Albumedix As GENE EXPRESSION TECHNIQUE
EP1816201A1 (en) 2006-02-06 2007-08-08 CSL Behring GmbH Modified coagulation factor VIIa with extended half-life
WO2007146038A2 (en) 2006-06-07 2007-12-21 Human Genome Sciences, Inc. Albumin fusion proteins
AU2007274035A1 (en) 2006-07-13 2008-01-17 Novozymes Biopharma Dk A/S Process for preparing particles of proteinaceous material
EP3243835B1 (en) 2009-02-11 2024-04-10 Albumedix Ltd Albumin variants and conjugates
GB2488077A (en) 2009-10-30 2012-08-15 Novozymes Biopharma Dk As Albumin variants
JP5969458B2 (ja) 2010-04-09 2016-08-17 アルブミディクス アクティーゼルスカブ アルブミン誘導体及び変異体
WO2012178102A2 (en) * 2011-06-24 2012-12-27 The Regents Of The Unversity Of Colorado, A Body Corporate Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
US20140315817A1 (en) 2011-11-18 2014-10-23 Eleven Biotherapeutics, Inc. Variant serum albumin with improved half-life and other properties
MX2014010278A (es) 2012-03-16 2015-03-05 Novozymes Biopharma Dk As Variantes de albumina.
CA2890766A1 (en) 2012-11-08 2014-05-15 Novozymes Biopharma Dk A/S Albumin variants
WO2014165093A2 (en) 2013-03-13 2014-10-09 Bristol-Myers Squibb Company Fibronectin based scaffold domains linked to serum albumin or a moiety binding thereto
AU2016308504A1 (en) 2015-08-20 2018-01-18 Albumedix Ltd. Albumin variants and conjugates
EP3538560A4 (en) * 2016-11-10 2020-06-17 Keros Therapeutics, Inc. GDNF FUSION POLYPEPTIDES AND METHODS OF USE

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE459586B (sv) * 1987-09-14 1989-07-17 Mta Szegedi Biolog Koezponti Strukturgen som kodar foer autentiskt humant serum albumin och foerfarande foer dess framstaellning
GB8725529D0 (en) * 1987-10-30 1987-12-02 Delta Biotechnology Ltd Polypeptides

Also Published As

Publication number Publication date
KR100227167B1 (ko) 1999-10-15
GB2246783B (en) 1992-10-14
GB9119043D0 (en) 1991-12-04
FI104255B (sv) 1999-12-15
EP0470165A1 (en) 1992-02-12
AU630450B2 (en) 1992-10-29
ZA903237B (en) 1991-03-27
WO1990013653A1 (en) 1990-11-15
AU5564690A (en) 1990-11-29
IE901554L (en) 1990-10-29
CA2015687C (en) 2000-08-29
GB8909916D0 (en) 1989-06-14
KR920701451A (ko) 1992-08-11
IL94243A (en) 1995-10-31
JPH04506598A (ja) 1992-11-19
HU904413D0 (en) 1992-01-28
FI915073A0 (fi) 1991-10-28
JP2781459B2 (ja) 1998-07-30
HUT61049A (en) 1992-11-30
CA2015687A1 (en) 1990-10-29
IL94243A0 (en) 1991-01-31
GB2246783A (en) 1992-02-12
IE67651B1 (en) 1996-04-17

Similar Documents

Publication Publication Date Title
FI104255B1 (sv) Förfarande för framsätllning av fusionsproteiner innehållande N-terminalfragmenter av mänsklig serumalbumin
KR100386762B1 (ko) 재조합사람혈청알부민의제조방법
EP0324647A3 (en) Vector for the expression of fusion proteins and protein immunogens
AU626183B2 (en) Chimaeric hepadnavirus core antigen proteins
EP0243929A3 (en) Polypeptide and protein derivatives and process for their preparation
PT86600A (pt) Process for the preparation of anticoagulant peptides
FI881743A0 (sv) Förfarande för framställning av bifunktionella proteiner
PT87688A (pt) Hybrid protein c and method for its preparation
DE3788807D1 (de) Fusionsproteine und -partikel.
ZA895821B (en) Method for the microbiological preparation of human serum albumin and other heterologous proteins from a yeast
AU4927390A (en) Fusion proteins
DK203087A (da) Fremgangsmaade til fremstilling af fusionsproteiner og anvendelse af det derved fremstillede fusionsprotein som vaccine
PT87207A (pt) Process for preparing recombinant htlv-iii proteins and uses thereof
AU1216988A (en) Immunogenic fusion proteins which contain Epstein-Barr virus protein
IL94526A0 (en) Method for c-terminal modification of proteins
DK284489A (da) Fusionsproteiner
DK241688A (da) Fremgangsmaade til fremstilling af fusionsproteiner
NO891926L (no) Fremgangsmaate for fremstilling av stabile protein- eller peptidpreparater.
IL89877A0 (en) Process for the preparation of proteins which start with n-terminal proline
HU895916D0 (en) Process for the preparation of monoclonal antibody recognaizing reg protein
IT8567469A0 (it) Procedimento per la preparazionedi n benzilossicarbonil amminoacidi contenenti funzionalita addizionali
GB8806571D0 (en) Supports for proteins & amino acids
GB8921227D0 (en) Antibodies and proteins
IE892830L (en) Fusion protein of paramyxovirus
DK362088D0 (da) Fusionsproteiner og fusionsproteinpartikler

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: NOVOZYMES DELTA LIMITED

Free format text: NOVOZYMES DELTA LIMITED

PC Transfer of assignment of patent

Owner name: NOVOZYMES BIOPHARMA UK LIMITED

Free format text: NOVOZYMES BIOPHARMA UK LIMITED